CHARLES HIGGS-COULTHARD: Open Payments
NPI 1447205448 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 30 payments from 18 companies in 2025. Trend: 2023 $136 · 2024 $782 · 2025 $590
Food & beverage: $572Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $64 |
| Amgen Inc. | 4 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| Lundbeck LLC | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Novo Nordisk Inc | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Corium, LLC | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $34 |
Products named: EVENITY, FANAPT, REXULTI, Qelbree, JARDIANCE, Azstarys, Kerendia, FARXIGA.
Industry payments across IN — which companies pay providers there.
